UBS AM’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding IDNA
WBG
UBS AM's IDNA Position: Q3 2026 in Review
UBS AM opened a new position in iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2026: 1,104 shares worth $46.7K. The stake represents ﹤0.01% of the portfolio and ranks #3431 among its holdings.
80 funds tracked by Wall St. Rank hold IDNA as of Q3 2026.
- UBS AM held 1,104 shares of iShares Genomics Immunology and Healthcare ETF worth $46.7K as of Q3 2026.
- iShares Genomics Immunology and Healthcare ETF was a new UBS AM position in Q3 2026.
- iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3431 holding.
- 80 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.